Repurposed Drug
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
14
NCT05347147
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 18, 2022
Completion: Oct 20, 2023
Loading map...